| Trial name or title |
Acute Stroke Treatment with Atorvastatin and Irbesartan (ASTART) |
| Methods |
Randomised, placebo‐controlled |
| Participants |
Clinical diagnosis of acute ischaemic stroke within 72 hours of onset |
| Interventions |
Atorvastatin (80 mg) + irbesartan (150 mg) versus placebo |
| Outcomes |
Effect on infarct size, cerebral perfusion and clinical outcome at 30 days |
| Starting date |
— |
| Contact information |
WA Centre for Health & Ageing (M573), University of Western Australia, 35 Stirling Highway, Crawley WA 6009, Australia |
| Notes |
— |
